United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $513,625,509.61
Most recent insider trade:
  • Oct. 3, 2022
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
Oct. 31, 2013CEO3,833$86.89Sell$333,049.37
Oct. 24, 2013CEO3,833$83.77Sell$321,090.41
Oct. 18, 2013COO10,000$82.47Sell$824,700.00
Oct. 17, 2013EVP6,000$81.79Sell$490,740.00
Oct. 17, 2013CFO2,750$82.01Sell$225,527.50
Oct. 17, 2013CEO3,833$81.84Sell$313,692.72
Oct. 10, 2013CEO3,833$82.58Sell$316,529.14
Oct. 4, 2013COO10,000$85.48Sell$854,800.00
Oct. 3, 2013Director1,500$83.15Sell$124,725.00
Oct. 3, 2013EVP6,000$84.38Sell$506,280.00
Oct. 3, 2013CEO3,833$84.20Sell$322,738.60
Oct. 3, 2013CFO4,500$84.67Sell$381,015.00
Sept. 26, 2013CEO3,833$78.41Sell$300,545.53
Sept. 20, 2013COO10,000$77.86Sell$778,600.00
Sept. 19, 2013CFO4,500$78.67Sell$354,015.00
Sept. 19, 2013EVP6,000$78.02Sell$468,120.00
Sept. 19, 2013CEO3,833$78.12Sell$299,433.96
Sept. 12, 2013CEO3,833$76.98Sell$295,064.34
Sept. 6, 2013COO10,000$73.67Sell$736,700.00
Sept. 5, 2013CEO3,833$73.63Sell$282,223.79
Sept. 5, 2013CFO4,500$74.17Sell$333,765.00
Sept. 5, 2013Director1,500$73.11Sell$109,665.00
Sept. 5, 2013EVP6,000$73.29Sell$439,740.00
Aug. 29, 2013CEO3,833$72.76Sell$278,889.08
Aug. 22, 2013CEO3,833$72.06Sell$276,205.98
Aug. 16, 2013COO10,000$71.21Sell$712,100.00
Aug. 15, 2013CFO4,500$71.14Sell$320,130.00
Aug. 15, 2013EVP6,000$71.34Sell$428,040.00
Aug. 15, 2013CEO3,833$71.58Sell$274,366.14
Aug. 8, 2013CEO3,833$73.11Sell$280,230.63
Aug. 2, 2013COO10,000$76.69Sell$766,900.00
Aug. 1, 2013Director3,000$75.94Sell$227,820.00
Aug. 1, 2013CEO3,833$75.97Sell$291,193.01
Aug. 1, 2013CFO4,500$75.87Sell$341,415.00
Aug. 1, 2013EVP6,000$75.91Sell$455,460.00
July 31, 2013Director7,500$74.93Sell$561,975.00
July 25, 2013CEO3,833$71.45Sell$273,867.85
July 19, 2013COO10,000$70.00Sell$700,000.00
July 18, 2013CEO3,833$68.96Sell$264,323.68
July 18, 2013CFO9,000$69.85Sell$628,650.00
July 18, 2013EVP6,000$69.15Sell$414,900.00
July 11, 2013CEO3,837$67.94Sell$260,685.78
July 5, 2013EVP6,000$67.04Sell$402,240.00
July 5, 2013Director1,500$66.33Sell$99,495.00
July 5, 2013COO10,000$67.21Sell$672,100.00
July 5, 2013CEO3,863$67.28Sell$259,902.64
June 21, 2013COO10,000$63.34Sell$633,400.00
June 20, 2013EVP6,000$63.29Sell$379,740.00
June 20, 2013CFO4,500$63.22Sell$284,490.00
June 7, 2013COO10,000$67.00Sell$670,000.00
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Roger Jeffs, Paul A Mahon, Martine A. Rothblatt, Martine Rothblatt, John Maxim Ferrari, Christopher Causey, Raymond Dwek, Paul Mahon, David Zaccardelli, Christopher Patusky, Richard Giltner, Tommy G Thompson, Judy D Olian, Louis W Sullivan, Paul A. Mahon, Ray Kurzweil, Louis Sullivan, Tommy G. Thompson, DWEK RAYMOND, Judy D. Olian, R Paul Gray, MAHON PAUL A, and Nilda Mesa

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 288 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $208,919,524.62.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on Oct. 3, 2022.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Roger Jeffs with a total value of $6,551,000.00 on Sept. 23, 2014.